Associate professor
Department of Pharmacology, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University
Address:5thteaching building 17#, Renmin Road South Chengdu, Sichuan
Phone Number:+86 28 85501378
Mobile:+8618980809646
Email Address:liuxiaokang6@163.com
Dr. Liu main research interests lie in the study of mechanisms of bacterial resistance. The focus Dr. Liu’s research program is to research and develop new antimicrobial drugs for the use of resistant bacterial. The ongoing program is the development of compound antibiotic with β-lactamase inhibitor.
Education and training
West china university of Medical Sciences, MD, Clinical Medicine, 1980
West china university of Medical Sciences, MM, Pharmacology, 1989
University of Verona, Italy, Microbiology, 1999-2000
Area of interest: Pharmacology, new Drug Research and Development, microbiology
Selected publications:
1. Junlong Li, Xiaoli Ji, Xiaohui Deng, Yingfeng Zhou, Xiaoqing Ni and Xiaokang Liu: Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacterium (English).BIOMEDICAL REPORTS, 2015, 3: 261-265
2. DENG Xiao-hui, LI Dong-xia, ZHENG Feng-jin, LIU Xiao-kang: In vitro antibacterial activity of Ceftriaxone/Sulbactan with different ratios (Chinese).West China Journal of Pharmaceutical Sciences, 2011, No 1, 49-51
3. TIAN Han-wen, LIU Xiao-kang, XIAO Yi, LI Jia-li: Preventive effect of Hericium Erinaceus on chronicatrophic gastritis in rats (Chinese).CHINESE JOURNAL OF HOSPITAL PHARMACY, 2009, Vol 29, No 20, 1764-1767
4. WU Hai-yan, LU Lan, LIU Xiao-kang: Comparing the antibacterial activities between Clarithromycin and Erythromycin in vitro and in vivo (Chinese).West China Journal of Pharmaceutical Sciences, 2010, No 1, 34-37
5. WANG Dejian, HUANG Yuanfang, LI Qiaoyun, XU Shijun, LIU Xiaokang: ANTI-APOPTOTIC EFFECT OF GINSENOSIDE Rg1 ON NEURON AFTER NEONATAL HYPOXIA ISCHEMIA BRAIN DAMAGE (Chinese).Chinese Journal of Reparative and Reconstructive Surgery, 2010, No 9, 1107-1112
6. ZHU Feimei, LI Junlong, LIU Rui, LI Xiaolong , WU Yong, LIU Xiaokang: Inhibition the growth of SKOV3 cells and inducation the expression of TFF1 by acetyltanshione ⅡA (Chinese).West China Journal of Pharmaceutical Sciences, 2016, No 1, 37-40
7. Zhu Fei-Mei , Li Jun-Long , Ni Xiao-Qing , Zhan Yan, Ruan Jia, Xu Chao-Qun, Liu Xiao-Kang: Effects of zhigui tablet on mice constipation induced by compound diphenoxylate (Chinese).Sichuan Journal of Physiological Sciences, 2015, No 1, 8-10
8. NI Xiao-qing, JI Xiao-li, LIU Xiao-kang: Drug resistance analysis and TEM genotypes of Klebsiella pneumoniae and Eschenchia coli producing ESBLs (Chinese).West China Journal of Pharmaceutical Sciences, 2013, No 6, 586-588
9. Li Jun-long, Xiong Mo-jun, Ni Xiao-qing, Ji Xiao-li, Liu Xiao-kang: Stability study of compatibility of potassium chloride sodium chloride injection and commonly used antimicrobial drugs (Chinese).Sichuan Journal of Physiological Sciences, 2013, No 2, 68-72
10. Huang Yuan-fang, Song Xiao-hong, Yin Ya-fei;, Zha La-gabaiyila;, Ji Xiao-li , Liu Xiao-kang: Detection of SHV gene point mutation of Pseudomonas aeruginosa by pyrosequencing (Chinese). Sichuan Journal of Physiological Sciences, 2012, No 1, 3-6
11. HUANG Yuanfang,SONG Xiaohong,YIN Yafei,ZHA Lagabaiyila,JI Xiaoli,LIU Xiaokang. Detection of SHV genotype of ESBLs-producing Gram-negative bacterium by pyrosequencing (Chinese).Laboratory Medicine, 2012, No 10, 829-834
12. LU Lan,HUANG Yuan-fang,JIA Qian-bin,DENG Yong,JIN Lei,LIU Xiao-kang: The preliminary study of tissue distribution of liver-targeted drug EVk in rats (Chinese).West China Journal of Pharmaceutical Sciences, 2011, No 3, 274-277
13. Song Xiao-hong,Yin Ya-fei,Huang Yuan-fang,Liu Xiao-kang: Detection of TEM,SHV and CTX-M genotype of ESBLs-producing gram-negative bacteria (Chinese).Sichuan Journal of Physiological Sciences, 2011, No 4, 154-156
14. DENG Xiao-hui,LI Dong-xia,ZHENG Feng-jin,LIU Xiao-kang: In vitro antibacterial activity of Ceftriaxone/Sulbactan with different ratios.West China Journal of Pharmaceutical Sciences, 2011, No 1, 49-51
15. WU Hai-yan, LU Lan, LIU Xiao-kang: Comparing the antibacterial activities between Clarithromycin and Erythromycin in vitro and in vivo (Chinese).West China Journal of Pharmaceutical Sciences, 2010, No 1, 34-37
16. WANG Dejian, HUANG Yuanfang , LI Qiaoyun , XU Shijun , LIU Xiaokang: ANTI-APOPTOTIC EFFECT OF GINSENOSIDE Rg1 ON NEURON AFTER NEONATAL HYPOXIA ISCHEMIA BRAIN DAMAGE (Chinese).Chinese Journal of Reparative and Reconstructive Surgery, 2010, No 9, 1107-1112
17. CHEN Su-wan, ZHANG Shou-chai, WANG Xiao-juan, SUN Ai-hui, DENG Xiao-hui, ZHENG Feng-jin, LI Bo, LIU Xiao-kang: In vitro antibacterial activities of different ratios from matching cefotaxime/tazobactam (Chinese).West China Journal of Pharmaceutical Sciences, 2009, No 1, 38-41
18. Wu Hai-yan, Liu Xiao-kang: Progress in molecular mechanism researchs of Helicobacter pylori resistance to clarithromycin (Chinese).Sichuan Journal of Physiological Sciences, 2009, No 3, 129-132
19. ZHANG Shou-chai,ZHANG Ling-ling,CHEN Su-wan,WU Hai-yan,LIU Xiao-kang: Post Antibiotic,Post β-lactamase Inhibitor and Post Antibiotic Sub-MIC Effect of Ceftriaxone/Tazobactam on beta-lactamase-producing Escherichia coli in vitro (Chinese).Journal of West China University of Medical Sciences, 2009，No 6, 1071-1074
20. ZHANG Shou-chai; CHEN Su-wan; WANG Xiao-juan; DENG Xiao-hui; SUN Ai-hui; ZHENG Feng-jin; LIU Xiao-kang: Antibacterial activities of different matching ratios of Ceftriaxone and Tazobactam in vitro (Chinese).West China Journal of Pharmaceutical Sciences, 2008, No 2, 143-146
21. Deng Xiao-hui, Zheng Feng-jin, He Wen-fu, Sun Ai-hui and Liu Xiaokang: In vitro study of mutant prevention concentration of fluoroquinolones for Klebsiella pneunoniae and its isogenic mutants strain (Chinese).Chinese Journal of Antibiotics, 2008, No 6, 10001-10004